Corporate Information And Statement Of Ifrs Compliance [Abstract]

Zealand Pharma - Filing #1440145

Concept	As at 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	Zealand Pharma A/S	—
Domicile of entity	—	Denmark	—
Legal form of entity	—	Parent and Consolidated	—
Country of incorporation	—	Denmark	—
Address of entity's registered office	—	Sydmarken 11. 2860 Søborg	—
Principal place of business	—	Denmark	—
Description of nature of entity's operations and principal activities	—	Selskabets formål er at drive forskning, produktion, handel og dermed beslægtet virksomhed, primært indenfor medicinalbranchen.	—
Name of parent entity	—	Zealand Pharma A/S	—
Name of ultimate parent of group	—	Zealand Pharma A/S	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories	65,040,000 DKK	—	0 DKK
Current trade receivables	46,484,000 DKK	—	751,000 DKK
Current trade payables	70,384,000 DKK	—	57,533,000 DKK